190 related articles for article (PubMed ID: 32165607)
1. Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
Ann Transplant; 2020 Mar; 25():e919414. PubMed ID: 32165607
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
World J Surg Oncol; 2019 Dec; 17(1):217. PubMed ID: 31830991
[TBL] [Abstract][Full Text] [Related]
3. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
He YF; Wang CQ; Yu Y; Qian J; Song K; Sun QM; Zhou J
PLoS One; 2015; 10(11):e0143657. PubMed ID: 26599011
[TBL] [Abstract][Full Text] [Related]
4. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
[TBL] [Abstract][Full Text] [Related]
5. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
World J Surg Oncol; 2019 Jun; 17(1):97. PubMed ID: 31170995
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
Obed A; Tsui TY; Schnitzbauer AA; Obed M; Schlitt HJ; Becker H; Lorf T
Langenbecks Arch Surg; 2008 Mar; 393(2):141-7. PubMed ID: 18043937
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
[TBL] [Abstract][Full Text] [Related]
8. An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?
Chui AK; Rao AR; McCaughan GW; Waugh R; Verran DJ; Koorey D; Painter D; Sheil AG
Clin Transplant; 1999 Dec; 13(6):531-5. PubMed ID: 10617245
[TBL] [Abstract][Full Text] [Related]
9. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.
Otto G; Heuschen U; Hofmann WJ; Krumm G; Hinz U; Herfarth C
Ann Surg; 1998 Mar; 227(3):424-32. PubMed ID: 9527066
[TBL] [Abstract][Full Text] [Related]
10. [TACE: therapy of the HCC before liver transplantation--experiences].
Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
[TBL] [Abstract][Full Text] [Related]
11. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK
Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111
[TBL] [Abstract][Full Text] [Related]
12. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.
Ravaioli M; Grazi GL; Ercolani G; Fiorentino M; Cescon M; Golfieri R; Trevisani F; Grigioni WF; Bolondi L; Pinna AD
Transplantation; 2004 Dec; 78(12):1780-6. PubMed ID: 15614151
[TBL] [Abstract][Full Text] [Related]
13. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma: the Baylor experience.
Onaca N; Klintmalm GB
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):559-66. PubMed ID: 19727543
[TBL] [Abstract][Full Text] [Related]
15. Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients.
Mao JX; Guo WY; Guo M; Liu C; Teng F; Ding GS
Hepatol Int; 2020 May; 14(3):347-361. PubMed ID: 32140981
[TBL] [Abstract][Full Text] [Related]
16. Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma.
Heinzow HS; Meister T; Nass D; Köhler M; Spieker T; Wolters H; Domschke W; Domagk D
Scand J Gastroenterol; 2011 Feb; 46(2):201-10. PubMed ID: 20969491
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
Zhang ZL; Liu ZS; Sun Q
World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
